Senior Editor with Pharma Manufacturing interviews Hesperos executives Michael Shuler and Nathan Post on the rise of Human-on-a-Chip (HoaC) systems and how they are replacing the need for animal testing in drug discovery.
ORLANDO, FLA – September 6, 2018 — Hesperos, Inc. announced today the receipt of a $4 million three-year NIH Phase IIb Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) National Center … Read More
Dr. We are pleased to announce Dr. Torston Hoffmann joining the Hesperos team as Senior Consultant for Drug Discovery. Dr. Hoffmann is currently the Chief Scientific Officer for Proteros biostructures in Munich, Germany. He is the … Read More